Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 921940 of 20,252 grants

Active NON-SBIR/STTR RPGS
Uncovering the Molecular Determinants of Metastatic Recurrence and Impaired NK Cell Function
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2024 – 2029

PROJECT SUMMARY Our proposed research employs innovative, unbiased approaches and novel preclinical models to elucidate how disseminated HER2+ breast cancer cells cells survive in...

$6.19M
USD
Active NON-SBIR/STTR RPGS
Targeting Senescence and the senescent secretome to impact breast cancer formation
NATIONAL CANCER INSTITUTE Oregon Health & Science University United States 2024 – 2026

Project Summary Senescence and the senescence associated secretory phenotype (SASP) have long been implicated in driving tumorigenesis. However, the pro-tumorigenic mechanism(s) of...

$3.96M
USD
Active NON-SBIR/STTR RPGS
Optimizing Theranostic Dosimetry and Kidney Biomarkers for Alpha-Emitter Radioligand Therapy in Neuroendocrine Tumors
NATIONAL CANCER INSTITUTE Research Inst Nationwide Children'S Hosp United States 2024 – 2029

SUMMARY The somatostatin subtype 2 receptor (SSTR2) is expressed in 80-100% of NETs. SSTR2 targeted alpha-emitter radioligand therapy (α-RLT) is emerging as an exciting alternative...

$6.28M
USD
Active NON-SBIR/STTR RPGS
A translational study of a synthetic lethality interaction of CD105 and androgen receptor signaling axis for castration-resistant prostate cancer patients
NATIONAL CANCER INSTITUTE Cedars-Sinai Medical Center United States 2024 – 2029

The goal of this proposal is to better understand a novel signaling axis initiated in prostate cancer (PCa) patients by next-generation androgen receptor signaling inhibitors (ARSI...

$5.54M
USD
Active NON-SBIR/STTR RPGS
Understanding mechanisms of BTK inhibitor and degrader resistance in patients with chronic lymphocytic leukemia
NATIONAL CANCER INSTITUTE University of Miami School of Medicine United States 2024 – 2029

Project Summary Covalent inhibitors of Bruton’s tyrosine kinase (BTK) are effective in multiple B-cell malignancies but patients discontinue these agents due to resistance and into...

$3.51M
USD
Active NON-SBIR/STTR RPGS
Multispectral imaging of bile duct epithelial morphology for early detection of malignancy
NATIONAL CANCER INSTITUTE Beth Israel Deaconess Medical Center United States 2024 – 2029

Project Summary Bile duct cancer, also known as cholangiocarcinoma, is the second most common primary liver cancer. It is considered to be an incurable cancer with no identifiable...

$6.97M
USD
Active NON-SBIR/STTR RPGS
Genetically-engineered Bacteria Overcome Therapy Resistance
NATIONAL CANCER INSTITUTE University of Chicago United States 2024 – 2029

Project Summary: For this proposal in response to PAR-22-085: Microbial-based Cancer Imaging and Therapy - Bugs as Drugs, we will focus on metastatic pancreatic ductal adenocarcino...

$5.81M
USD
Active NON-SBIR/STTR RPGS
Targeting metabolic stress response to improve CAR-T cell efficacy.
NATIONAL CANCER INSTITUTE Methodist Hospital Research Institute United States 2024 – 2026

Project Summary T cell-based immune therapies are a promising approach to treat cancer. Chimeric antigen receptor (CAR) is one such therapy developed by engineering a protein compr...

$4.15M
USD
Active NON-SBIR/STTR RPGS
Reducing toxicity from prostate cancer radiotherapy through genetics and technology
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT There is an incredible need to find new biomarkers to improve our ability to personalize cancer therapy, to identify those that will have toxicity from tre...

$3.6M
USD
Active NON-SBIR/STTR RPGS
Unravel the novel role of S100A7 and its functional partners in Metastatic Triple Negative Breast Cancer Racial Disparity
NATIONAL CANCER INSTITUTE Ohio State University United States 2024 – 2029

Triple-negative breast cancer (TNBC) disproportionately affects African American (AA) women, with mortality rates 65% higher than Caucasian (CA) women. The mechanisms underlying th...

$4.7M
USD
Active NON-SBIR/STTR RPGS
Frontiers in Bone Metastatic Models for Prostate Cancer
NATIONAL CANCER INSTITUTE University of Connecticut Sch of Med/Dnt United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT Metastasis is responsible for more than 90% of prostate cancer-related mortality and remains a considerable challenge in developing effective and durable t...

$4.23M
USD
Active NON-SBIR/STTR RPGS
A generalizable model of normal tissue recovery to enable personalized re-irradiation
NATIONAL CANCER INSTITUTE University of Washington United States 2024 – 2026

Our current clinical approach to re-irradiation is not based on data. Guidelines vary widely and are not rooted in observed toxicities. A frequently cited reason for that is both t...

$4M
USD
Active NON-SBIR/STTR RPGS
Combination optical imaging to guide transoral laser microsurgery in larynx cancer
NATIONAL CANCER INSTITUTE University of Alabama At Birmingham United States 2024 – 2026

PROJECT SUMMARY Nearly 13,000 new cases of laryngeal cancer are diagnosed in the U.S. annually. Transoral laser microsurgery (TLM) has become the primary surgical approach for earl...

$3.75M
USD
Active NON-SBIR/STTR RPGS
A study of IDH1-mutant prostate cancer to identify novel therapeutic targets
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2024 – 2026

Abstract While over 90% of patients with metastatic prostate cancer respond to systemic therapies that block androgen receptor signaling, nearly all of these patients will eventual...

$4.21M
USD
Active NON-SBIR/STTR RPGS
Molecular mechanisms of allele-specific NRAS signaling and tumorigenesis
NATIONAL CANCER INSTITUTE Ohio State University United States 2024 – 2029

ABSTRACT Cancer-associated RAS mutants were once considered oncogenic equivalents. However, it is increasingly clear that mutants of the same RAS isoform (H-, K- or NRAS) and amino...

$6.41M
USD
Active NON-SBIR/STTR RPGS
Role of Grail in colon inflammation and tumorigenesis
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT Chronic intestinal inflammation is a major risk factor for the development of colorectal cancer (CRC). It is well- acknowledged that pro-inflammatory cytok...

$1.64M
USD
Active NON-SBIR/STTR RPGS
Investigating KIF20A as a therapeutic target in glioblastoma
NATIONAL CANCER INSTITUTE Ohio State University United States 2024 – 2026

Project Summary/Abstract Elevated expression of KIF20A, a mitotic kinesin required to promote cytokinesis, the final step of cell division, is a near-universal feature of human can...

$4.05M
USD
Active NON-SBIR/STTR RPGS
Tumor-Activated Dual Payload-Drug Conjugates
NATIONAL CANCER INSTITUTE Washington State University United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT Targeting the hallmark biomarker prostate specific membrane antigen (PSMA) has been a successful small molecule drug-delivery strategy for various payloads...

$3.93M
USD
Active NON-SBIR/STTR RPGS
Epigenetic re-establishment of tumor suppression in glioblastoma
NATIONAL CANCER INSTITUTE Cold Spring Harbor Laboratory United States 2024 – 2029

PROJECT SUMMARY This project focuses on a new epigenetic vulnerability of human glioblastoma (GBM), the most common and deadly adult primary brain malignancy. We discovered the bro...

$6.79M
USD
Active NON-SBIR/STTR RPGS
Understanding lung cancer genomics in patients of African ancestry
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2024 – 2029

PROJECT SUMMARY Lung cancer is the leading cause of cancer death among the African American population. Although many actionable biomarkers and targeted treatments are available to...

$7.3M
USD